Cash Flow Statement (Annual)

UVE / Universal Insurance Holdings, Inc. Short Interest

UVE / Universal Insurance Holdings, Inc. Cash Flow Statement shows changes in cash positions over time. Cash Flow Statement data includes Cash from Operating Activities (CFOP), Cash from Investing Activities, and Cash from Financing Activities.

All numbers are times 1,000 except per share units.

2009 2010 2011 2012 2013 2014 2015 2016 2017
Net Cash Provided By Used In Operating Activities
  Net Cash Provided By Used In Operating Activities 20,817 -4,060 110,129 141,997 156,959 - - - -
Net Cash Provided By Used In Investing Activities
  Proceeds From Sale Of Other Property Plant And Equipment - - - 28 8 84 86 36 23
  Payments To Acquire Property Plant And Equipment 762 1,714 2,395 2,726 1,350 9,267 11,869 8,223 4,618
  Payments To Acquire Available For Sale Securities Equity 206,054 80,730 - - 77,859 116,541 65,038 66,688 89,302
  Payments To Acquire Available For Sale Securities Debt 325,674 129,141 - - 305,330 106,885 178,198 320,131 180,604
  Payments To Acquire Real Estate Held For Investment - - - - - - 6,220 5,496 7,218
  Proceeds From Sale Of Available For Sale Securities Equity 147,635 70,681 - - 15,542 163,981 41,456 60,558 77,640
  Proceeds From Sale Of Available For Sale Securities Debt 299,033 116,238 - - - 17,153 38,379 86,018 26,179
  Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities - - - - 16,306 24,287 74,390 54,615 97,191
  Proceeds From Sale Maturity And Collection Of Shortterm Investments - - - - - - 100,000 25,000 5,000
  Net Cash Provided By Used In Investing Activities -85,822 -24,634 -2,331 -2,698 -352,683 - - - -
Net Cash Provided By Used In Financing Activities
  Payments Of Dividends Preferred Stock And Preference Stock 27 20 20 287 29 13 10 10 10
  Payments Of Dividends Common Stock 20,313 12,533 12,750 18,669 17,725 19,240 22,287 24,192 24,001
  Proceeds From Stock Options Exercised - - - - - 73 511 119 -
  Payments For Repurchase Of Common Stock - - - - 32,366 29,736 18,649 8,510 18,141
  Payments Related To Tax Withholding For Share Based Compensation 223 4,292 172 121 3,161 17,655 12,141 5,451 7,223
  Repayments Of Debt 368 1,471 1,471 1,471 1,471 7,471 8,470 2,136 2,170
  Net Cash Provided By Used In Financing Activities -15,551 -11,470 -11,758 -21,592 -34,393 - - - -
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
  Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect - - - - - - - - -
  Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents - - - - - - - - -

Peers - Fire, Marine, and Casualty Insurance (6331)

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

CUSIP: 91359V107